Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology.
about
Efficacy and tolerability of pharmacotherapy options for the treatment of irritability in autistic childrenAripiprazole partial agonism at 5-HT2C: a comparison of weight gain associated with aripiprazole adjunctive to antidepressants with high versus low serotonergic activitiesThe neurodevelopmental hypothesis of schizophrenia, revisitedThe evolution of drug development in schizophrenia: past issues and future opportunities.Adjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial.Aripiprazole Facilitates Extinction of Conditioned Fear in Adolescent Rats.The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.Handwriting movement kinematics for quantifying extrapyramidal side effects in patients treated with atypical antipsychotics.Physicochemical drug properties associated with in vivo toxicological outcomes: a review.Voltammetric and mathematical evidence for dual transport mediation of serotonin clearance in vivoDeveloping therapeutics for schizophrenia and other psychotic disorders.Profile of aripiprazole in the treatment of bipolar disorder in children and adolescentsInteraction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies.Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapseEfficacy and safety of aripiprazole in child and adolescent patientsTardive dyskinesia: treatment with aripiprazole.Role of aripiprazole in treating mood disorders.Iloperidone: a new benzisoxazole atypical antipsychotic drug. Is it novel enough to impact the crowded atypical antipsychotic market?Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic reviewAripiprazole augmentation in managing comorbid obsessive-compulsive disorder and bipolar disorder: a case with suicidal attempts.Aripiprazole: in the treatment of irritability associated with autistic disorder in pediatric patients.Quinoline- and isoquinoline-sulfonamide analogs of aripiprazole: novel antipsychotic agents?Use of aripiprazole for delirium in the elderly: a short review.Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine ModulationAripiprazole, a Drug that Displays Partial Agonism and Functional Selectivity.Practitioner Review: The effects of atypical antipsychotics and mood stabilisers in the treatment of depressive symptoms in paediatric bipolar disorder.Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways.Pharmacologic analysis of non-synonymous coding h5-HT2A SNPs reveals alterations in atypical antipsychotic and agonist efficacies.Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia.Worsened hypertension control induced by aripiprazole.Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole.A case of intention tremor induced by the combination of aripiprazole and lamotrigineAripiprazole an atypical antipsychotic protects against ethanol induced gastric ulcers in rats.Aripiprazole in an animal model of chronic alcohol consumption and dopamine D₂ receptor occupancy in rats.Striatal and extrastriatal dopamine D₂ receptor occupancy by the partial agonist antipsychotic drug aripiprazole in the human brain: a positron emission tomography study with [¹¹C]raclopride and [¹¹C]FLB457.Effects of antipsychotic treatment on cognition in healthy subjects.Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study.Do we do what we know works, and if not why not?Diabetic ketoacidosis associated with aripiprazole.
P2860
Q24564288-79B5E152-5CFC-4D4C-BA8A-D3D9CBE22E5DQ24615556-A415A0FE-AD82-4EBB-87FE-274368C195AFQ24658343-1FD9B211-4162-45D4-93E3-924F1A545CE7Q30487850-E420B4FC-194E-4B7B-B31D-5AA8950CFDD9Q30490025-5F10E706-ACAD-4EA8-BE44-3B761E527B16Q33650040-F4AB2F74-5D77-4137-81ED-C138B0210652Q33706833-7ABF67D8-6345-46A5-88F7-D4EAE6CA2BDEQ33811763-10DD62AE-3851-4EF3-A924-37B65BD97756Q33845886-C6FA7F54-FB48-4052-8712-C5207C15FFABQ33934982-096313BA-CD6F-414D-B141-1C78CF0C7E4DQ33946985-5E1B85E5-A231-462B-A9DF-73D33982ECD2Q34600500-350CBB13-09E1-4E6F-BB9A-623ED693D3CFQ34605085-1CC0FD05-5410-4794-B140-AB0EC38BD001Q35062881-BA3B15A5-0D01-4A30-AAE9-E41423E6E336Q36075828-159871AA-1C7A-46CD-A704-454939B0FB8DQ36599203-B350242C-021B-4CDE-9A60-7E8F11652A21Q36688973-320BBD89-622E-423E-BD82-A7E058304ADCQ37038991-77E62F1F-AA73-499F-B478-806E53D023F1Q37299210-920D7781-5C8B-4C1A-9F48-440794D33CB3Q37551946-093A0D1A-743B-449A-9B0F-935C9680E094Q37866291-B97DBF1C-4427-4543-8FCA-1FBEB512421CQ38172958-1CB319F6-496B-45D6-A35C-F47B4EC6DDCAQ38290683-7247210D-F5D3-41BA-A1B1-60015EB7A543Q39041217-B69D6D5D-2913-4304-A6CE-1AA4854DB112Q39244947-FED1B2BA-2B17-42EF-8374-E152F94D80F6Q39285492-035A0F7B-7BD3-40F4-90BE-82278ADCAEBEQ39749438-844BB9E8-259B-4A4C-996A-59B7C88F9389Q40346338-4698847E-7C4C-41F0-ADE4-ADF1C7AD7145Q40571585-92486130-0079-4248-B8EC-B3B469EB9A0CQ41147400-FD3AF6A5-50CB-4179-989B-76446FDA1C21Q41433244-EB4F648A-2954-444A-9487-FB3B55BC8844Q41528294-5C88DD27-9CEC-4709-9349-DF65A558E032Q42175937-58BEB9C5-97DB-486F-9E97-A8461E0BF89DQ42873823-566783A0-2341-421F-A78D-D9BB0A80B8A9Q43746151-8C276F18-DBB6-4063-952C-5F3231E2C1A0Q44009699-4EFE18CA-57AC-445A-9BE8-EC56C0A784B4Q45743617-C1D55499-E7BD-4A6D-AC5F-F7A7BBCB432CQ45990613-94178D50-2D20-499D-A51D-96EB7A035EF2Q46382367-0D840DA0-5A23-403E-B24D-4193AB2FDA04Q46408003-C3604AB0-111C-489A-9D96-C7E4CCE9AFEE
P2860
Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology.
@ast
Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology.
@en
Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology.
@nl
type
label
Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology.
@ast
Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology.
@en
Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology.
@nl
prefLabel
Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology.
@ast
Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology.
@en
Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology.
@nl
P2093
P2860
P1476
Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology
@en
P2093
Bryan L Roth
Douglas J Sheffler
Marilyn A Davies
P2860
P304
P356
10.1111/J.1527-3458.2004.TB00030.X
P577
2004-01-01T00:00:00Z